SELLAS Life Sciences Group, Inc.
NASDAQ:SLSBiotechnology
Healthcare
$17.95 +4.02%
+$0.31 today
- Market cap
- $3.66B
- Beta
- 2.53
- P/E (TTM)
- -47.3
- EPS (TTM)
- -$0.17
52W Low $1.39High $9.51
Volume 35.53M
Average 7.79M
Price history
SELLAS Life Sciences Group, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+1028.93%
Period high
$19.15
Period low
$1.39
Latest
$17.95
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| SC 13G/A | Oct 27, 2026 | Oct 27, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| SC 13G | Jul 31, 2026 | Jul 31, 2026 | |
| 8-K | Jul 27, 2026 | Jul 27, 2026 | |
| 8-K | Jun 25, 2026 | Jun 25, 2026 | |
| 8-K | Jun 18, 2026 | Jun 18, 2026 | |
| 4 | Jun 18, 2026 | Jun 18, 2026 | |
| S-8 | Jun 16, 2026 | Jun 16, 2026 | |
| 8-K | Jun 2, 2026 | Jun 2, 2026 | |
| 10-Q | May 12, 2026 | May 12, 2026 |
Competitors
Who does SELLAS Life Sciences Group, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about SLS's filings, answered from its disclosures.
What is the latest SLS filing?
The latest filing shown is 10-Q dated Nov 12, 2026.
How many recent filings does SLS have?
Intrinsic Alpha currently shows 20 recent filings for SLS.
Continue the stock analysis
Jump to another research area for this company.